Does BROLUCIZUMAB-DBLL Cause Eye inflammation? 387 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 387 reports of Eye inflammation have been filed in association with BROLUCIZUMAB-DBLL. This represents 13.8% of all adverse event reports for BROLUCIZUMAB-DBLL.
387
Reports of Eye inflammation with BROLUCIZUMAB-DBLL
13.8%
of all BROLUCIZUMAB-DBLL reports
2
Deaths
10
Hospitalizations
How Dangerous Is Eye inflammation From BROLUCIZUMAB-DBLL?
Of the 387 reports, 2 (0.5%) resulted in death, 10 (2.6%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Eye inflammation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB-DBLL. However, 387 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB-DBLL Cause?
Vitreous floaters (479)
Visual impairment (446)
Vision blurred (416)
Visual acuity reduced (365)
Retinal vasculitis (323)
Uveitis (305)
Vitritis (284)
Eye pain (234)
Vitreous opacities (205)
Anterior chamber cell (199)
What Other Drugs Cause Eye inflammation?
DUPILUMAB (876)
AFLIBERCEPT (875)
ADALIMUMAB (709)
CENEGERMIN-BKBJ (190)
ETANERCEPT (176)
CYCLOSPORINE (150)
RANIBIZUMAB (146)
METHOTREXATE (139)
FARICIMAB-SVOA (136)
SECUKINUMAB (135)
Which BROLUCIZUMAB-DBLL Alternatives Have Lower Eye inflammation Risk?
BROLUCIZUMAB-DBLL vs BROMAZEPAM
BROLUCIZUMAB-DBLL vs BROMFENAC
BROLUCIZUMAB-DBLL vs BROMHEXINE
BROLUCIZUMAB-DBLL vs BROMOCRIPTINE
BROLUCIZUMAB-DBLL vs BROTIZOLAM